Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
| Fund Name: | RA Capital Management |
| Manager | Peter Kolchinsky |
| Portfolio Value | $3,165,729,000 |
| Change This QTR | +0.96% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | ASND | 4,914,955 | $553,473 | +18% | 17.48% | |
| 2. | RARX | 4,858,260 | $233,245 | 7.36% | ||
| 3. | CCXI | 4,176,910 | $167,828 | +31% | 5.3% | |
| 4. | ARVN | 3,672,872 | $148,017 | 4.67% | ||
| 5. | ZGNX | 5,275,538 | $130,464 | +134% | 4.12% |
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2019-11-13 | ||||
| 2019-11-08 | ||||
| 2019-10-18 | ||||
| 2019-10-11 |
We use tracking technologies to enhance your user experience and to provide you service. By using Insider Monkey, you are giving us consent. Privacy Policy
